Skip to content
Clinical Trials – home
Vividion Therapeutics Inc.
Sponsor

Vividion Therapeutics Inc.

United States 10075 Barnes Canyon Road Suite 100, 92121-2780, United States

About the sponsor

Vividion Therapeutics Inc. focuses on early clinical research in advanced solid tumours, with studies centred on safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumour activity. Its portfolio includes first-in-human evaluation of novel oncology agents in patients with refractory solid tumours.

  • First-in-human oncology
  • Anti-tumour activity
  • Solid tumour malignancies

The sponsor’s work in this area extends across dose escalation and dose expansion settings, reflecting a strong interest in identifying therapeutic activity in difficult-to-treat tumour populations.

About Specializations

Vividion Therapeutics Inc. runs clinical trials in conditions such as Colorectal adenocarcinoma, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Colorectal adenocarcinoma

Not yet recruiting

Phase 2 Study of ro7589831 with Pembrolizumab vs Pembrolizumab Alone in Adults with Advanced Colorectal Cancer (MSI‑High or dMMR)

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Vividion Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.